2016 IMS Recommendations on women's midlife health and menopause hormone therapy

被引:641
作者
Baber, R. J. [1 ]
Panay, N. [1 ]
Fenton, A. [1 ]
机构
[1] Univ Sydney, Sydney Med Sch North, Obstet & Gynaecol, Sydney, NSW 2006, Australia
关键词
hormone replacement therapy; midlife health; Menopause hormone therapy; HRT; Recommendations; IMS; ESTROGEN PLUS PROGESTIN; PREMATURE OVARIAN FAILURE; CORONARY-HEART-DISEASE; VULVO-VAGINAL ATROPHY; BONE-MINERAL DENSITY; QUALITY-OF-LIFE; CONJUGATED EQUINE ESTROGEN; BREAST-CANCER RISK; TRANSDERMAL ESTROGEN/PROGESTERONE REGIMENS; POSTMENOPAUSAL WOMEN;
D O I
10.3109/13697137.2015.1129166
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The International Menopause Society (IMS) has produced these new 2016 recommendations on women's midlife health and menopause hormone therapy (MHT) to help guide health-care professionals in optimizing their management of women in the menopause transition and beyond. The term MHT has been used to cover therapies including estrogens, progestogens and combined regimens. For the first time, the 2016 IMS recommendations now include grades of recommendations, levels of evidence and 'good practice points', in addition to section-specific references. Where possible, the recommendations are based on and linked to the evidence that supports them, unless good-quality evidence is absent. Particular attention has been paid to published evidence from 2013 onwards, the last time the IMS recommendations were updated. Databases have been extensively searched for relevant publications using key terms specific to each specialist area within menopause physiology and medicine. Information has also been drawn from international consensus statements published by bodies such as the IMS, the European Menopause and Andropause Society and the North American Menopause Society. The recommendations have been produced by experts derived mainly from the IMS, with the assistance of key collaborators where deemed advantageous. In preparing these international recommendations, experts have taken into account geographical variations in medical care, prevalence of diseases, and country-specific attitudes of the public, medical community and health authorities towards menopause management. The variation in availability and licensing of MHT and other products has also been considered.
引用
收藏
页码:109 / 150
页数:42
相关论文
共 348 条
[1]   The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal-Ottawa New Emerging Team group study [J].
Abdulnour, Joseph ;
Doucet, Eric ;
Brochu, Martin ;
Lavoie, Jean-Marc ;
Strychar, Irene ;
Rabasa-Lhoret, Remi ;
Prud'homme, Denis .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (07) :760-767
[2]  
ACOG, 2012, Obstet Gynecol, V120, P197, DOI [10.1097/AOG.0b013-318262e320, DOI 10.1097/AOG.0B013E318262E320]
[3]   A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials of DHEA Treatment Effects on Quality of Life in Women with Adrenal Insufficiency [J].
Alkatib, Aziz A. ;
Cosma, Mihaela ;
Elamin, Mohamed B. ;
Erickson, Dana ;
Swiglo, Brian A. ;
Erwin, Patricia J. ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (10) :3676-3681
[4]   Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition [J].
Allen, Naomi E. ;
Tsilidis, Konstantinos K. ;
Key, Timothy J. ;
Dossus, Laure ;
Kaaks, Rudolf ;
Lund, Eiliv ;
Bakken, Kjersti ;
Gavrilyuk, Oxana ;
Overvad, Kim ;
Tjonneland, Anne ;
Olsen, Anja ;
Fournier, Agnes ;
Fabre, Alban ;
Clavel-Chapelon, Francoise ;
Chabbert-Buffet, Nathalie ;
Sacerdote, Carlotta ;
Krogh, Vittorio ;
Bendinelli, Benedetta ;
Tumino, Rosario ;
Panico, Salvatore ;
Bergmann, Manuela ;
Schuetze, Madlen ;
van Duijnhoven, Fraenzel J. B. ;
Bueno-de-Mesquita, H. Bas ;
Onland-Moret, N. Charlotte ;
van Gils, Carla H. ;
Amiano, Pilar ;
Barricarte, Aurelio ;
Chirlaque, Maria-Dolores ;
Molina-Montes, Maria-Esther ;
Redondo, Maria-Luisa ;
Duell, Eric J. ;
Khaw, Kay-Tee ;
Wareham, Nick ;
Rinaldi, Sabina ;
Fedirko, Veronika ;
Mouw, Traci ;
Michaud, Dominique S. ;
Riboli, Elio .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 172 (12) :1394-1403
[5]  
American College of Obstetricians and Gynecologists, 2012, OBSTET GYNECOL, V120, P411, DOI DOI 10.1097/AOG.0B013E318268049E
[6]   Prior hormone therapy and breast cancer risk in the Women's Health initiative randomized trial of estrogen plus progestin [J].
Anderson, Garnet L. ;
Chlebowski, Rowan T. ;
Rossouw, Jacques E. ;
Rodabough, Rebecca J. ;
McTiernan, Anne ;
Margolis, Karen L. ;
Aggerwal, Anita ;
Curb, J. David ;
Hendrix, Susan L. ;
Hubbell, F. Allan ;
Khandekar, Jamardan ;
Lane, Dorothy S. ;
Lasser, Norman ;
Lopez, Ana Maria ;
Potter, JoNell ;
Ritenbaugh, Cheryl .
MATURITAS, 2006, 55 (02) :103-115
[7]   Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial [J].
Anderson, Garnet L. ;
Chlebowski, Rowan T. ;
Aragaki, Aaron K. ;
Kuller, Lewis H. ;
Manson, JoAnn E. ;
Gass, Margery ;
Bluhm, Elizabeth ;
Connelly, Stephanie ;
Hubbell, F. Allan ;
Lane, Dorothy ;
Martin, Lisa ;
Ockene, Judith ;
Rohan, Thomas ;
Schenken, Robert ;
Wactawski-Wende, Jean .
LANCET ONCOLOGY, 2012, 13 (05) :476-486
[8]   Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures - The Women's Health Initiative randomized trial [J].
Anderson, GL ;
Judd, HL ;
Kaunitz, AM ;
Barad, DH ;
Beresford, SAA ;
Pettinger, M ;
Liu, J ;
McNeeley, SG ;
Lopez, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13) :1739-1748
[9]   Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].
Anderson, GL ;
Limacher, M ;
Assaf, AR ;
Bassford, T ;
Beresford, SAA ;
Black, H ;
Bonds, D ;
Brunner, R ;
Brzyski, R ;
Caan, B ;
Chlebowski, R ;
Curb, D ;
Gass, M ;
Hays, J ;
Heiss, G ;
Hendrix, S ;
Howard, BV ;
Hsia, J ;
Hubbell, A ;
Jackson, R ;
Johnson, KC ;
Judd, H ;
Kotchen, JM ;
Kuller, L ;
LaCroix, AZ ;
Lane, D ;
Langer, RD ;
Lasser, N ;
Lewis, CE ;
Manson, J ;
Margolis, K ;
Ockene, J ;
O'Sullivan, MJ ;
Phillips, L ;
Prentice, RL ;
Ritenbaugh, C ;
Robbins, J ;
Rossouw, JE ;
Sarto, G ;
Stefanick, ML ;
Van Horn, L ;
Wactawski-Wende, J ;
Wallace, R ;
Wassertheil-Smoller, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712
[10]   The 2012 Hormone Therapy Position Statement of The North American Menopause Society [J].
不详 .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (03) :257-271